These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 29746951)

  • 1. Oligonucleotide aptamers: promising and powerful diagnostic and therapeutic tools for infectious diseases.
    Pan Q; Luo F; Liu M; Zhang XL
    J Infect; 2018 Aug; 77(2):83-98. PubMed ID: 29746951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligonucleotide aptamers for pathogen detection and infectious disease control.
    Wan Q; Liu X; Zu Y
    Theranostics; 2021; 11(18):9133-9161. PubMed ID: 34522231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aptamers against pathogenic microorganisms.
    Davydova A; Vorobjeva M; Pyshnyi D; Altman S; Vlassov V; Venyaminova A
    Crit Rev Microbiol; 2016 Nov; 42(6):847-65. PubMed ID: 26258445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aptamer for imaging and therapeutic targeting of brain tumor glioblastoma.
    Delač M; Motaln H; Ulrich H; Lah TT
    Cytometry A; 2015 Sep; 87(9):806-16. PubMed ID: 26189784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection of Nucleic Acid Aptamers Specific for Mycobacterium tuberculosis.
    Mozioglu E; Gokmen O; Tamerler C; Kocagoz ZT; Akgoz M
    Appl Biochem Biotechnol; 2016 Feb; 178(4):849-64. PubMed ID: 26541162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of ssDNA aptamers that inhibit rabies virus.
    Liang HR; Hu GQ; Zhang T; Yang YJ; Zhao LL; Qi YL; Wang HL; Gao YW; Yang ST; Xia XZ
    Int Immunopharmacol; 2012 Nov; 14(3):341-7. PubMed ID: 22771543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of Complex Target SELEX to Identify Aptamers against Mammalian Cell-Surface Antigens.
    Mallikaratchy P
    Molecules; 2017 Jan; 22(2):. PubMed ID: 28146093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA and RNA aptamers: from tools for basic research towards therapeutic applications.
    Ulrich H; Trujillo CA; Nery AA; Alves JM; Majumder P; Resende RR; Martins AH
    Comb Chem High Throughput Screen; 2006 Sep; 9(8):619-32. PubMed ID: 17017882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aptamers as Therapeutic Agents: Has the Initial Euphoria Subsided?
    Haßel SK; Mayer G
    Mol Diagn Ther; 2019 Jun; 23(3):301-309. PubMed ID: 31037641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of DNA aptamers against Escherichia coli using a bacterial cell-systematic evolution of ligands by exponential enrichment approach.
    Kim YS; Song MY; Jurng J; Kim BC
    Anal Biochem; 2013 May; 436(1):22-8. PubMed ID: 23357235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic applications of nucleic acid aptamers in microbial infections.
    Afrasiabi S; Pourhajibagher M; Raoofian R; Tabarzad M; Bahador A
    J Biomed Sci; 2020 Jan; 27(1):6. PubMed ID: 31900238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hi-Fi SELEX: A High-Fidelity Digital-PCR Based Therapeutic Aptamer Discovery Platform.
    Ouellet E; Foley JH; Conway EM; Haynes C
    Biotechnol Bioeng; 2015 Aug; 112(8):1506-22. PubMed ID: 25727321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aptamers: molecular tools for medical diagnosis.
    Ozalp VC; Kavruk M; Dilek O; Bayrac AT
    Curr Top Med Chem; 2015; 15(12):1125-37. PubMed ID: 25866272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SELEX methods on the road to protein targeting with nucleic acid aptamers.
    Bayat P; Nosrati R; Alibolandi M; Rafatpanah H; Abnous K; Khedri M; Ramezani M
    Biochimie; 2018 Nov; 154():132-155. PubMed ID: 30193856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aptamers: new arrows to target dendritic cells.
    Ganji A; Varasteh A; Sankian M
    J Drug Target; 2016; 24(1):1-12. PubMed ID: 25950603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of a high-affinity and in vivo bioactive ssDNA aptamer against angiotensin II peptide.
    Heiat M; Ranjbar R; Latifi AM; Rasaee MJ
    Peptides; 2016 Aug; 82():101-108. PubMed ID: 27298205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening and development of DNA aptamers specific to several oral pathogens.
    Park JP; Shin HJ; Park SG; Oh HK; Choi CH; Park HJ; Kook MS; Ohk SH
    J Microbiol Biotechnol; 2015 Mar; 25(3):393-8. PubMed ID: 25269812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro evolution of chemically-modified nucleic acid aptamers: Pros and cons, and comprehensive selection strategies.
    Lipi F; Chen S; Chakravarthy M; Rakesh S; Veedu RN
    RNA Biol; 2016 Dec; 13(12):1232-1245. PubMed ID: 27715478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ssDNA aptamers that recognize diclofenac and 2-anilinophenylacetic acid.
    Joeng CB; Niazi JH; Lee SJ; Gu MB
    Bioorg Med Chem; 2009 Aug; 17(15):5380-7. PubMed ID: 19604698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medicinal chemistry of aptamers.
    Veedu RN
    Curr Top Med Chem; 2015; 15(12):1065. PubMed ID: 25866280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.